Relay Therapeutics, Inc.

RLAY

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001812364

SEC filings (opens in a new tab)

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Relay Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of RLAY: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	140	3	148	+11
Shares	113.1M	93.4K	120.6M	+7.59M (+6.7%)
Value	$3.38B	$2.80M	$2.02B	−$1.36B (−40.3%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RLAY in Q2 2022
Institution	Shares	Value	% of portfolio
Avoro Capital Advisors LLC	400,000	$6.70M	0.13%
Trexquant Investment LP	183,287	$3.07M	0.14%
Gsa Capital Partners LLP	178,593	$2.99M	0.45%
Qube Research & Technologies Ltd	59,484	$996.0K	0.01%
Two Sigma Investments, LP	23,909	$400.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	23,739	$397.0K	0.00%
HighTower Advisors, LLC	17,941	$302.0K	0.00%
Janus Henderson Group PLC	16,782	$281.0K	0.00%
First Trust Advisors LP	14,383	$241.0K	0.00%
Capital Impact Advisors, LLC	12,839	$215.0K	0.20%
SEI Investments Co	12,323	$204.0K	0.00%
Dynamic Technology Lab Private Ltd	11,930	$200.0K	0.02%
National Bank of Canada	1,000	$17.0K	0.00%
Dark Forest Capital Management LP	577	$10.0K	0.00%
TCI Wealth Advisors, Inc.	412	$7.00K	0.00%
State of Wyoming	304	$5.00K	0.00%
Captrust Financial Advisors	13	$0	0.00%
CWM, LLC	27	$0	0.00%
JFS Wealth Advisors, LLC	10	$0	0.00%
Parallel Advisors, LLC	12	$0	0.00%
Rockefeller Capital Management L.P.	1	$0	0.00%
Disciplined Investments, LLC	1	$0	0.00%
Bell Investment Advisors, Inc	28	$0	0.00%
Schubert & Co	6	$0	0.00%
Steward Financial Group LLC	8	$0	0.00%

Sold out (14)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RLAY in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Tudor Investment Corp Et Al	33,922	$1.01M
Laurion Capital Management LP	20,000	$599.0K
NinePointTwo Capital	17,670	$528.0K
Nomura Asset Management Co Ltd	14,000	$419.0K
Handelsbanken Fonder AB	8,500	$254.0K
American Financial Group Inc	7,484	$224.0K
Vontobel Holding Ltd.	7,413	$222.0K
Caption Management, LLC	5,000	$149.0K
Simplex Trading, LLC	2,710	$81.0K
STRS Ohio	800	$23.0K
US Bancorp	235	$7.00K
Signaturefd, LLC	51	$2.00K
Allworth Financial LP	8	$0
Capital Advisors, Ltd. LLC	4	$0

Not filed for Q2 2022 yet (3)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	75,283	$2.25M
Amalgamated Financial Corp.	11,087	$332.0K
Susquehanna Fundamental Investments, LLC	7,051	$211.0K